Get your fresh news on health and wellness in Alabama

Provided by AGP

Got News to Share?

Health News of Alabama: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.

Press releases published on April 16, 2026

EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026
Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences
Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine
Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases
Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
Soleo Health Appoints Joy Rowan as New Senior Vice President of Sales to Drive Strategic Growth Initiatives
Nula Therapeutics Launches with up to $20 Million ARPA-H Award to Advance a New Class of Medicines Targeting the Nuclear Envelope of Cells
Remedy Plan Therapeutics Announces Multiple Presentations at the AACR Annual Meeting 2026
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function
Harrow Announces the Issuance of J-Code for IOPIDINE® 1%
Adlai Nortye Announces $150.0 Million Private Placement Equity Financing
MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia
ATUM Welcomes Gavin Barnard, Ph.D., as Chief Scientific Officer

Share us

on your social networks:

Sign up for:

Health News of Alabama

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.